share_log

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fifth Third Bancorp

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Fifth Third Bancorp

AXON企業公司(納斯達克代碼:AXON)被Five Third Bancorp收購的股票
Defense World ·  2022/07/11 16:21

Fifth Third Bancorp grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 28.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 676 shares of the biotechnology company's stock after purchasing an additional 150 shares during the period. Fifth Third Bancorp's holdings in Axon Enterprise were worth $93,000 as of its most recent filing with the Securities & Exchange Commission.

據Five Third Bancorp在最近提交給美國證券交易委員會的13F文件中稱,該公司在第一季度增持了Axon Enterprise,Inc.(納斯達克代碼:Axon-Get Rating)28.5%的股份。該基金持有這家生物技術公司676股股票,在此期間又購買了150股。截至最近提交給美國證券交易委員會(Securities&Exchange Commission)的文件,Five Third Bancorp持有的Axon Enterprise價值9.3萬美元。

Several other institutional investors have also made changes to their positions in the company. Highland Capital Management LLC lifted its stake in shares of Axon Enterprise by 4.8% in the 1st quarter. Highland Capital Management LLC now owns 15,971 shares of the biotechnology company's stock valued at $2,200,000 after purchasing an additional 732 shares during the last quarter. Waypoint Capital Advisors LLC acquired a new position in shares of Axon Enterprise in the 1st quarter valued at $1,363,000. State of Alaska Department of Revenue lifted its stake in Axon Enterprise by 1.3% during the 1st quarter. State of Alaska Department of Revenue now owns 9,636 shares of the biotechnology company's stock worth $1,327,000 after acquiring an additional 120 shares in the last quarter. Yarbrough Capital LLC lifted its stake in Axon Enterprise by 28.8% during the 1st quarter. Yarbrough Capital LLC now owns 2,207 shares of the biotechnology company's stock worth $304,000 after acquiring an additional 494 shares in the last quarter. Finally, Baldwin Brothers LLC MA acquired a new position in Axon Enterprise during the 1st quarter worth about $62,000. 72.06% of the stock is currently owned by institutional investors and hedge funds.

其他幾家機構投資者也對他們在該公司的頭寸進行了調整。高地資本管理有限責任公司在第一季度增持了4.8%的Axon Enterprise股票。Highland Capital Management LLC現在擁有這家生物技術公司15,971股股票,價值220萬美元,上個季度又購買了732股。Way Point Capital Advisors LLC在第一季度收購了Axon Enterprise的新頭寸,價值1,363,000美元。阿拉斯加州税務局在第一季度增持了Axon Enterprise 1.3%的股份。阿拉斯加州税務局在上個季度增持了120股後,現在持有這家生物技術公司9636股股票,價值1,327,000美元。Yarbough Capital LLC在第一季度增持了Axon Enterprise 28.8%的股份。在上個季度增持了494股後,Yarbough Capital LLC現在持有這家生物技術公司2,207股股票,價值30.4萬美元。最後,鮑德温兄弟有限責任公司在第一季度收購了Axon Enterprise的一個新頭寸,價值約62,000美元。72.06%的股票目前由機構投資者和對衝基金持有。

Get
到達
Axon Enterprise
Axon企業
alerts:
警報:

AXON has been the topic of several research reports. Robert W. Baird decreased their target price on Axon Enterprise from $145.00 to $125.00 in a research note on Wednesday, May 11th. Morgan Stanley lowered Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 target price on the stock. in a research note on Monday, May 23rd. Credit Suisse Group initiated coverage on Axon Enterprise in a research note on Monday, May 9th. They set an "outperform" rating and a $169.00 target price on the stock. StockNews.com raised Axon Enterprise from a "hold" rating to a "buy" rating in a research note on Saturday, June 18th. Finally, Northland Securities decreased their target price on Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $172.89.

軸突一直是幾份研究報告的主題。羅伯特·W·貝爾德在5月11日星期三的一份研究報告中將Axon Enterprise的目標價從145.00美元下調至125.00美元。摩根士丹利將Axon Enterprise的評級從“增持”下調至“持平”,併為該股設定120.00美元的目標價.在5月23日星期一的一份研究報告中。瑞士信貸集團在5月9日星期一的一份研究報告中啟動了對Axon Enterprise的報道。他們為該股設定了“跑贏大盤”的評級和169.00美元的目標價。在6月18日星期六的一份研究報告中,StockNews.com將Axon Enterprise的評級從持有上調至買入。最後,Northland Securities在5月12日星期四的一份研究報告中將Axon Enterprise的目標價從180.00美元下調至130.00美元。一名股票研究分析師對該股的評級為持有,8名分析師給出了買入評級,一名分析師對該公司股票給予了強烈的買入評級。根據MarketBeat.com的數據,該公司目前的平均評級為買入,共識目標價為172.89美元。

Shares of NASDAQ AXON opened at $96.85 on Monday. Axon Enterprise, Inc. has a 1-year low of $82.49 and a 1-year high of $209.00. The company has a market cap of $6.88 billion, a price-to-earnings ratio of 186.25 and a beta of 0.61. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.43 and a quick ratio of 2.18. The stock's 50-day moving average is $94.77 and its two-hundred day moving average is $118.06.
週一,納斯達克Axon的股價開盤報96.85美元。Axon Enterprise,Inc.的一年低點為82.49美元,一年高位為209.00美元。該公司市值為68.8億美元,市盈率為186.25,貝塔係數為0.61.該公司的債務權益比為0.02,流動比率為2.43,速動比率為2.18。該股的50日移動均線切入位在94.77美元,200日移動均線切入位在118.06美元。

Axon Enterprise (NASDAQ:AXON – Get Rating) last released its quarterly earnings data on Tuesday, May 10th. The biotechnology company reported $0.76 EPS for the quarter. Axon Enterprise had a return on equity of 3.90% and a net margin of 4.62%. The business had revenue of $256.43 million for the quarter, compared to the consensus estimate of $233.57 million. During the same quarter in the prior year, the business posted ($0.75) EPS. The business's revenue for the quarter was up 31.5% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc. will post 1.35 earnings per share for the current fiscal year.

Axon Enterprise(納斯達克:Axon-Get Rating)最近一次發佈季度收益數據是在5月10日(星期二)。這家生物技術公司公佈本季度每股收益為0.76美元。Axon Enterprise的股本回報率為3.90%,淨利潤率為4.62%。該業務本季度的收入為2.5643億美元,而普遍預期為2.3357億美元。在前一年的同一季度,該業務公佈了每股收益(0.75美元)。該業務當季營收較上年同期增長31.5%。股票研究分析師預計,Axon Enterprise,Inc.本財年每股收益將達到1.35美元。

In other news, Director Mark W. Kroll sold 3,159 shares of the stock in a transaction dated Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the transaction, the director now owns 13,691 shares in the company, valued at approximately $1,407,708.62. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 6.90% of the company's stock.

其他新聞方面,董事馬克·克羅爾在一筆日期為6月8日(星期三)的交易中出售了3159股該公司股票。這隻股票的平均售價為102.82美元,總價值為324,808.38美元。交易完成後,董事現在擁有該公司13,691股股份,價值約1,407,708.62美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,可以通過這個超級鏈接獲得。公司內部人士持有該公司6.90%的股份。

About Axon Enterprise (Get Rating)

關於Axon Enterprise(獲取評級)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Axon Enterprise,Inc.在美國和國際上以泰瑟品牌開發、製造和銷售導電能源設備(CED)。它通過兩個部分運作,泰瑟槍和軟件和傳感器。該公司還提供硬件和基於雲的軟件解決方案,使執法部門能夠捕獲、安全存儲、管理、共享和分析視頻和其他數字證據。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
  • Five Below Stock is a Recession Play
  • Here's How to Dollar Cost Average into Positions in a Bear Market
  • MarketBeat: Week in Review 7/4 – 7/8
  • Levi Strauss Proves Resilient For Dividend Investors
  • AT&T (NYSE:T) Is Its Cheaper Valuation Worth A Buy?
  • 免費獲取StockNews.com關於Axon Enterprise(Axon)的研究報告
  • 《五股之下》是一部經濟衰退劇
  • 以下是如何將平均成本轉化為熊市頭寸的方法
  • MarketBeat:回顧中的一週7/4-7/8
  • 列維·施特勞斯被證明對股利投資者具有彈性
  • 美國電話電報公司(紐約證券交易所代碼:T)較低的估值值得買入嗎?

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

接受Axon企業日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收Axon Enterprise和相關公司的最新新聞和分析師評級的每日簡明摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論